NVAX
NASDAQ · Biotechnology
Novavax Inc
$9.13
-0.37 (-3.89%)
Open$9.68
Previous Close$9.50
Day High$9.99
Day Low$9.08
52W High$11.97
52W Low$6.13
Volume—
Avg Volume4.64M
Market Cap1.50B
P/E Ratio—
EPS$-0.61
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+216.3% upside
Current
$9.13
$9.13
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.10B | 1.33B | 441.16M |
| Net Income | 430.04M | 467.66M | -6,729,988 |
| Profit Margin | 39.2% | 37.2% | -1.5% |
| EBITDA | 441.16M | 506.41M | -8,036,743 |
| Free Cash Flow | — | — | -9,195,591 |
| Rev Growth | -17.2% | -17.2% | +6.7% |
| Debt/Equity | 0.75 | 0.75 | 0.98 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |